| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 182 | 2022 |
| Integron and its role in antimicrobial resistance: A literature review on some bacterial pathogens P Sabbagh, M Rajabnia, A Maali, E Ferdosi-Shahandashti Iranian journal of basic medical sciences 24 (2), 136, 2021 | 67 | 2021 |
| Various signaling pathways in multiple myeloma cells and effects of treatment on these pathways A Dehghanifard, S Kaviani, S Abroun, M Mehdizadeh, S Saiedi, A Maali, ... Clinical Lymphoma Myeloma and Leukemia 18 (5), 311-320, 2018 | 51 | 2018 |
| A review on leukemia and iPSC technology: application in novel treatment and future A Maali, A Atashi, S Ghaffari, R Kouchaki, F Abdolmaleki, M Azad Current Stem Cell Research & Therapy 13 (8), 665-675, 2018 | 35 | 2018 |
| Nanobodies in cell-mediated immunotherapy: On the road to fight cancer A Maali, M Gholizadeh, S Feghhi-Najafabadi, A Noei, SS Seyed-Motahari, ... Frontiers in immunology 14, 1012841, 2023 | 24 | 2023 |
| CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy F Maroufi, A Maali, M Abdollahpour-Alitappeh, MH Ahmadi, M Azad Epigenomics 12 (20), 1845-1859, 2020 | 18 | 2020 |
| Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics A Maali, F Maroufi, F Sadeghi, A Atashi, R Kouchaki, M Moghadami, ... Epigenomics 13 (08), 631-647, 2021 | 17 | 2021 |
| National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019 A Aryannejad, S Saeedi Moghaddam, B Mashinchi, M Tabary, N Rezaei, ... Breast Cancer Research 25 (1), 47, 2023 | 15 | 2023 |
| Updates on novel erythropoiesis-stimulating agents: Clinical and molecular approach Z Moradi, A Maali, JS Shad, A Farasat, R Kouchaki, M Moghadami, ... Indian Journal of Hematology and Blood Transfusion 36, 26-36, 2020 | 14 | 2020 |
| Single-nucleotide polymorphisms in host pattern-recognition receptors show association with antiviral responses against SARS-CoV-2, in-silico trial H Teimouri, A Maali Journal of Medical Microbiology and Infectious Diseases 8 (2), 65-70, 2020 | 13 | 2020 |
| The study of nurses knowledge and performance quality of Qazvin hospitals about the process of blood transfusion F Nemati, A Maali, MH Ahmadi, H Poorkarim, H Rahmani, ZS Tabatabaei, ... Advances in Nursing & Midwifery 28 (2), 14-18, 2019 | 12 | 2019 |
| Therapeutic approaches and vaccination in fighting COVID-19 infections: A review S Adibzadeh, S Amiri, GE Nia, MR Taleghani, ZK Bijarpas, N Maserat, ... Gene reports 27, 101619, 2022 | 7 | 2022 |
| Detection of bacterial agents causing prostate infection by culture and molecular methods from biopsy specimens AA Karami, A Javadi, S Salehi, N Nasirian, A Maali, MB Shadkam, ... Iranian Journal of Microbiology 14 (2), 161, 2022 | 7 | 2022 |
| Drug switching, a creative approach to leukemia therapy A Maali, E Ferdosi-Shahandashti, M Azad Iranian Journal of Blood and Cancer 11 (3), 111-112, 2019 | 6 | 2019 |
| The incidence of ABO, Kell and Rh system blood groups in general population of Qazvin, Iran MH Ahmadi, F Maroufi, H Kelki, N Zolghadri, F Moradi, A Maali, M Azad Archives of Advances in Biosciences 9 (4), 42-46, 2018 | 6 | 2018 |
| The antihelminthic drug, mebendazole, induces apoptosis in adult T-cell leukemia/lymphoma cancer cells: in-vitro trial A Maali, E Ferdosi-Shahandashti, F Sadeghi, E Aali International Journal of Hematology-Oncology and Stem Cell Research 14 (4), 257, 2020 | 5 | 2020 |
| NiFe2O4/ZnO-coated Poly(L-Lactide) nanofibrous scaffold enhances osteogenic differentiation of human mesenchymal stem cells S Shariati, E Seyedjafari, FS Mahdavi, A Maali, E Ferdosi-Shahandashti Frontiers in Bioengineering and Biotechnology 10, 1005028, 2022 | 4 | 2022 |
| Induced pluripotent stem cell meets severe combined immunodeficiency R Kouchaki, B Abd-Nikfarjam, A Maali, S Abroun, F Foroughi, S Ghaffari, ... Cell Journal (Yakhteh) 22 (Suppl 1), 1, 2020 | 4 | 2020 |
| Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells T Hojjatipour, Z Sharifzadeh, A Maali, M Azad Human Cell 36 (6), 1843-1864, 2023 | 2 | 2023 |
| Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy MR Lahimchi, F Maroufi, A Maali Cellular Reprogramming 25 (5), 195-211, 2023 | 2 | 2023 |
Dr. Elaheh Ferdosi-ShahandashtiAssistant Professor and Head of Medical Biotechnology Department, School of Medicine in Babol在 mubabol.ac.ir 的电子邮件经过验证
